Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder
PHASE2CompletedINTERVENTIONAL
Timeline
Start Date
October 31, 2002
Primary Completion Date
May 31, 2004
Study Completion Date
November 30, 2006
Conditions
Extrahepatic Bile Duct CancerGallbladder Cancer
Interventions
DRUG
capecitabine
DRUG
gemcitabine hydrochloride
Trial Locations (1)
14263-0001
Roswell Park Cancer Institute, Buffalo
All Listed Sponsors
lead
Roswell Park Cancer Institute
OTHER
NCT00084942 - Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder | Biotech Hunter | Biotech Hunter